Search Results 401-410 of 15419 for desimone

1. A Study of PRN1008 in Patients With Pemphigus - Mayo Clinic

   The purpose of this study is to evaluate the effectiveness and safety of oral PRN1008 in moderate to severe pemphigus. Participation eligibility. Participant ...

2. A Study Trying Laser Technology to Assess Human Blood - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

3. A Study of the Use of Pembrolizumab (MK-3475) in Patients with Relapsed or Hard to Treat Classical Hodgkin Lymphoma - Mayo Clinic

   The purpose of this study is to use pembrolizumab for patients with relapsed or hard to treat classical Hodgkins Lymphoma. The primary study hypothesis is that ...

4. Publications - Nancy L. Wengenack, Ph.D. - Mayo Clinic

   DeSimone DC, Heaton PR, Neff BA, Dao LN, Wengenack NL, Fadel HJ. A rare case of chronic otitis externa due to Mycobacterium tuberculosis. J Clin Tuberc ...

5. Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML) - Mayo Clinic

   About this study. Phase I Dose Escalation: To investigate the MTD, safety, efficacy and pharmacokinetics of volasertib in combination with decitabine in ...

6. Study of Dexamethasone Plus IXAZOMIB or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis - Mayo Clinic

   Treatment options will include: dexamethasone alone, dexamethasone plus an alkylating agent (melphalan or cyclophosphamide), or dexamethasone plus an ...

7. A Study of an Implantable System for Remodulin Post Approval - Mayo Clinic

   The purposes of this study is to estimate the freedom from catheter-related complications through 5 years post-implant and to estimate the freedom from ISR pump ...

8. A Study to Evaluate the Patterns of Use of Biological Agents and Risk Factors for Discontinuation of Agents in Pediatric Crohn’s Disease (CD) and Ulcerative Colitis (UC) within the Pediatric Population - Mayo Clinic

   This population will be queried for biologic use prior to age 18. The study population for the remainder of the study will be all CD and UC patients in ICN who ...

9. Cediranib Maleate and Selumetinib in Treating Patients With Solid Malignancies - Mayo Clinic

   Cediranib maleate and selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Cediranib maleate may also stop the ...

10. A Study to Investigate the Effects of GC4419 on Radiation-Induced Oral Mucositis in Patients With Head/Neck Cancer - Mayo Clinic

    The purpose of this study is to determine if GC4419, administered prior to intensity-modulated radiation therapy (IMRT), reduces the severity of radiation- ...